Male enhancement therapy is now being offered in Canada, and it may soon be available in the U.S.
The treatment has been in the works for more than a decade, but was only recently approved in Canada.
The medical marijuana company Therapeutic Goods and Research (TGR) is currently seeking to apply for a Canadian licence to sell the product.
In a statement, the company says that it expects to apply in 2019.
It says it is in talks with both the Health Canada and the U of S. Food and Drug Administration regarding its product.
It’s not known if the treatment is available in other countries.
TGR’s website says it’s also developing a topical medication for the treatment of depression and post-traumatic stress disorder.
The company’s website notes that its product is also used to treat anxiety and migraines.TGR says it plans to make the drug available through its Therapeutics and Pharmacotherapy division.
It is not known what the price of the drug will be, but the company states that it will cost between $300 and $400 per pill.